Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050596

Expand all

CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER (CEFOTAXIME SODIUM)
EQ 20MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFOTAXIME SODIUM
Proprietary Name: CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050596
Product Number: 002
Approval Date: May 20, 1985
Applicant Holder Full Name: STERIMAX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER (CEFOTAXIME SODIUM)
EQ 40MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFOTAXIME SODIUM
Proprietary Name: CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050596
Product Number: 004
Approval Date: May 20, 1985
Applicant Holder Full Name: STERIMAX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (CEFOTAXIME SODIUM)
EQ 20MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFOTAXIME SODIUM
Proprietary Name: CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050596
Product Number: 001
Approval Date: May 20, 1985
Applicant Holder Full Name: STERIMAX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (CEFOTAXIME SODIUM)
EQ 40MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFOTAXIME SODIUM
Proprietary Name: CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 40MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050596
Product Number: 003
Approval Date: May 20, 1985
Applicant Holder Full Name: STERIMAX INC
Marketing Status:  Discontinued
Patent and Exclusivity Information